Skip to main content
. 2020 Mar 26;43(6):1986–1994. doi: 10.3892/or.2020.7566

Figure 4.

Figure 4.

Costunolide treatment decreases the migrative ability of H1299 lung cancer cells in vitro. (A) H1299 cells were treated with different concentrations of costunolide for 24 h and the mobility rates were observed via wound healing assays. (B) Data are presented as the mean ± standard deviation (n=3). Differences between concentrations were tested using one-way ANOVA and Tukey's post hoc tests. *P<0.05, **P<0.01. Con, control.